metlife inc. - MET
MET
Close Chg Chg %
80.36 0.04 0.05%
Closed Market
80.40
+0.04 (0.05%)
Volume: 2.90M
Last Updated:
Jun 30, 2025, 3:59 PM EDT
Company Overview: metlife inc. - MET
MET Key Data
Open $80.18 | Day Range 80.03 - 80.54 |
52 Week Range 65.21 - 89.03 | Market Cap $53.95B |
Shares Outstanding 671.30M | Public Float 561.52M |
Beta 0.84 | Rev. Per Employee N/A |
P/E Ratio 13.08 | EPS $6.19 |
Yield 274.05% | Dividend $0.57 |
EX-DIVIDEND DATE May 6, 2025 | SHORT INTEREST N/A |
AVERAGE VOLUME 2.83M |
MET Performance
1 Week | 0.06% | ||
1 Month | 2.34% | ||
3 Months | 16.43% | ||
1 Year | 14.57% | ||
5 Years | 125.58% |
MET Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
19
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | OVERWEIGHT | Average Target Price | 93.786 | |
Number of Ratings | 19 | Current Quarters Estimate | 2.37 | |
FY Report Date | 09 / 2025 | Current Year's Estimate | 9.089 | |
Last Quarter’s Earnings | 2.31 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 8.15 | Next Fiscal Year Estimate | 10.309 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 15 | 15 | 16 | 16 |
Mean Estimate | 2.37 | 2.44 | 9.09 | 10.31 |
High Estimates | 2.56 | 2.70 | 9.65 | 10.80 |
Low Estimate | 2.13 | 2.26 | 8.70 | 9.90 |
Coefficient of Variance | 4.51 | 4.63 | 2.96 | 2.58 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 12 | 12 | 12 |
OVERWEIGHT | 2 | 2 | 1 |
HOLD | 5 | 5 | 6 |
UNDERWEIGHT | 0 | 0 | 1 |
SELL | 0 | 0 | 0 |
MEAN | Overweight | Overweight | Overweight |
SEC Filings for Metlife Inc. - MET
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Metlife Inc. - MET
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Apr 4, 2025 | Cheryl W. Grisé Director | 88,189 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 7,157,419.24 |
Apr 4, 2025 | Carlos Miguel Gutierrez Director | 23,289 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 4, 2025 | Edward Joseph Kelly Director | 36,849 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 2,990,664.84 |
Apr 4, 2025 | William E. Kennard Director | 42,739 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 3,468,697.24 |
Apr 4, 2025 | Robert Glenn Hubbard Director | 98,875 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 8,024,695.00 |
Apr 4, 2025 | David Lawrence Herzog Director | 26,138 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 2,121,360.08 |
Apr 4, 2025 | Carla A. Harris Director | 7,897 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 640,920.52 |
Apr 4, 2025 | Denise M. Morrison Director | 32,255 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Apr 4, 2025 | Laura J. Hay Director | 3,116 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 252,894.56 |
Apr 4, 2025 | Jeh Charles Johnson Director | 6,183 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 501,812.28 |
Apr 4, 2025 | Diana L. McKenzie Director | 21,350 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $81.16 per share | 1,732,766.00 |
Apr 4, 2025 | Mark Alan Weinberger Director | 16,345 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 6, 2025 | Tamara L. Schock EVP & Chief Accounting Officer | 23,606 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share | 2,023,034.20 |
Mar 6, 2025 | Ramy Tadros President, U.S. Business | 181,368 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share | 15,543,237.60 |
Mar 6, 2025 | William Pappas EVP, Global Tech. & Ops. | 85,746 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share | 7,348,432.20 |
Mar 6, 2025 | Marlene B. Debel EVP & Chief Risk Officer | 134,135 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share | 11,495,369.50 |
Mar 6, 2025 | Monica Melchionni Curtis EVP & Chief Legal Officer | 14,872 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share | 1,274,530.40 |
Mar 6, 2025 | John D. McCallion EVP & Chief Financial Officer | 245,129 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share | 21,007,555.30 |
Mar 6, 2025 | Michel A. Khalaf President & CEO; Director | 612,483 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $85.7 per share | 52,489,793.10 |
Feb 28, 2025 | Shurawl Sibblies EVP & Chief HR Officer | 21,884 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Metlife Inc. in the News
Wall Street CEOs demand Biden and Congress fix NYC migrant crisis
More than 100 CEOs and business leaders in New York City are calling for federal action to fix the United States' broken immigration system and address the migrant crisis.